Evidence map›Paper›PMID 31023224›Full record

ArticleBMC microbiology2019

Genetic resistance determinants to fusidic acid and chlorhexidine in variably susceptible staphylococci from dogs.

S-M Frosini, R Bond, M Rantala, T Grönthal, S C Rankin, K O'Shea, D Timofte, V Schmidt, J Lindsay, A Loeffler

Abstract read
In one paragraph

Article in BMC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The dynamic interplay betweenFrontiers in cellular and infection microbiology · 2026
    Review
  6. Genomic analysis of theFrontiers in microbiology · 2025
    Article
  7. In Vitro Activity ofVeterinary sciences · 2024
    Article
  8. Prevalence and anti-microbial resistance ofVeterinary research forum : an international quarterly journal · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

S-M FrosiniDepartment of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK. sfrosini@rvc.ac.uk.ORCID 0000-0003-4601-4566
R BondDepartment of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK.
M RantalaDepartment of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, P.O. Box 57, 00014, Helsinki, Finland.
T GrönthalDepartment of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, P.O. Box 57, 00014, Helsinki, Finland.
S C RankinDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3850 Spruce Street, Philadelphia, PA, 19104, USA.
K O'SheaDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3850 Spruce Street, Philadelphia, PA, 19104, USA.
D TimofteInstitute of Veterinary Science, University of Liverpool, Chester High Road, Neston, CH64 7TE, UK.
V SchmidtInstitute of Veterinary Science, University of Liverpool, Chester High Road, Neston, CH64 7TE, UK.
J LindsayInstitute of Infection and Immunity, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK.
A LoefflerDepartment of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/K011952/1
6 · The paper itself

Abstract

backgroundConcern exists that frequent use of topically-applied fusidic acid (FA) and chlorhexidine (CHX) for canine pyoderma is driving clinically relevant resistance, despite rare description of FA and CHX genetic resistance determinants in canine-derived staphylococci. This study aimed to determine minimum inhibitory concentrations (MICs) and investigate presence of putative resistance determinants for FA and CHX in canine-derived methicillin-resistant (MR) and -susceptible (MS) staphylococci. Plasmid-mediated resistance genes (fusB, fusC, fusD, qacA/B, smr; PCR) and MICs (agar dilution) of FA and CHX were investigated in 578 staphylococci (50 MR S. aureus [SA], 50 MSSA, 259 MR S. pseudintermedius [SP], 219 MSSP) from Finland, U.S.A., North (NUK) and South-East U.K. (SEUK) and Germany. In all isolates with FA MIC ≥64 mg/L (n = 27) fusA and fusE were amplified and sequenced.

resultsFA resistance determinants (fusA mutations n = 24, fusB n = 2, fusC n = 36) were found in isolates from all countries bar U.S.A. and correlated with higher MICs (≥1 mg/L), although 4 SP isolates had MICs of 0.06 mg/L despite carrying fusC. CHX MICs did not correlate with qacA/B (n = 2) and smr (n = 5), which were found in SEUK SA, and SP from NUK and U.S.A.

conclusionsIncreased FA MICs were frequently associated with fusA mutations and fusC, and this is the first account of fusB in SP. Despite novel description of qacA/B in SP, gene presence did not correlate with CHX MIC. Selection pressure from clinical use might increase prevalence of these genetic determinants, but clinical significance remains uncertain in relation to high skin concentrations achieved by topical therapy.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsChlorhexidineDisinfectantsDogsDrug Resistance, Multiple, BacterialFinlandFusidic AcidGermanyMethicillin ResistanceMicrobial Sensitivity TestsPeptide Elongation Factor GPyodermaR FactorsStaphylococcusAnti-Bacterial AgentsBacterial ProteinsChlorhexidineDisinfectantsFusA protein, Staphylococcus aureusFusidic AcidPeptide Elongation Factor GCanineChlorhexidineFusidic acidResistanceStaphylococciVeterinary

Identifiers

PMID31023224
PMCPMC6485160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.